Carbonic anhydrase 9 (CA IX) is highly expressed and active in the plasma-derived sEVs of PCa patients compared to normal subjects; therefore, CA IX in sEVs may be a biomarker of PCa progression [105]. This evidence concerns the gene CA9 and posterior cortical atrophy.